WB analysis of membrane-enriched extracts (30 microg lysate) of L6 using GTX23481 Myosin VIIa antibody. Dilution : 5 microg/ml
WB analysis of membrane-enriched extracts (30 microg lysate) of L6 using GTX23481 Myosin VIIa antibody. Dilution : 5 microg/ml
Myosin VIIa antibody
GTX23481
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityMouse, Rat
TargetMyo7a
Overview
- SupplierGeneTex
- Product NameMyosin VIIa antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 3-6 microg/ml. ICC/IF: 2 microg/ml. FACS: 3-5 microg/106 cells. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID17921
- Target nameMyo7a
- Target descriptionmyosin VIIA
- Target synonymsHdb; motor protein; Myo; Myo7; myosin-VIIa; nmf37; nmf371; p; polka; sh1; sh-1; shaker 1; unconventional myosin-VIIa; USH1; USH1B
- HostRabbit
- IsotypeIgG
- Protein IDP97479
- Protein NameUnconventional myosin-VIIa
- Scientific DescriptionMyosin VIIa is a member of the myosin superfamily of actin-based motor proteins. Defects in the myosin VIIa gene are responsible for hearing impairment in shaker-1 (sh1) mice and causes Usher syndrome IB in humans. Usher syndrome associates congenital deafness, vestibular dysfunction, and retinitis pigmentosa and is the most common form of combined deafness and blindness. Structural features of myosin VIIa protein include an ATP binding N-terminal motor domain, a central region which possess five light-chain binding (IQ) motifs, and a C-terminal domain with three myosin tail homology (MyTH4) and talin-like homology regions.
- ReactivityMouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203